Cost-effectiveness of acupuncture for irritable bowel syndrome: Findings from an economic evaluation conducted alongside a pragmatic randomised controlled trial in primary care

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Stamuli, Eugena ^a   Bloor, Karen ^a   MacPherson, Hugh ^a   Tilbrook, Helen ^a   Stuardi, Tracy ^a   Brabyn, Sally ^a   Torgerson, David ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Acupuncture; Economic evaluation; Health technology assessment; Irritable bowel syndrome; Quality of life

Indexed keywords

ACUPUNCTURE; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; COST UTILITY ANALYSIS; DISEASE SEVERITY; HEALTH CARE COST; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT CARE; PRIMARY MEDICAL CARE; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

ACUPUNCTURE THERAPY; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; COST-BENEFIT ANALYSIS; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; IRRITABLE BOWEL SYNDROME; PRIMARY HEALTH CARE; QUALITY-ADJUSTED LIFE YEARS; SEVERITY OF ILLNESS INDEX;

EID: 84867662438     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-149     Document Type: Article

References (23)

1. Rey E, Talley NJ. Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Digestive and Liver Disease 2009, 41:772-780.
2. Lea R, Whorwell PJ. Quality of life in irritable bowel syndrome. Pharmacoeconomics 2001, 19:643-653.
3. Akehurst RL, Brazier JE, Mathers N, O'Keefe C, Kaltenthaler E, et al. Health-related quality of life and cost impact of irritable bowel syndrom in a UK primary care setting. Pharmacoeconomics 2002, 20:455-462.
4. Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther 1997, 11.
5. Wells NEJ, Hahn BA, Whorwell PJ. Clinical economics review: irritable bowel syndrome. Aliment Pharmacol Ther 1997, 11:10119-11030.
6. Creed F, Ratcliffe J, Fernandez L, Tomenson B, Palmer S, et al. Health-Related Quality of Life and Health Care Costs in Severe, Refractory Irritable Bowel Syndrome. Ann Intern Med 2001, 134:860-868.
7. Hahn B, Yan S, Strassels S. Impact of irritable bowel syndrome on quality of life and resource us in the United States and United Kingdom. Digestion 1999, 60:77-81.
8. Akehurst R, Kaltenthaler E. Treatment of irritable bowel syndrome: a review of randomised controlled trials. Gut 2001, 48:272-282.
9. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997, 112:2120-2137.
10. Lim B, Manheimer E, Lao L, Ziea E, Wisniewski J, Liu J, et al. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2006, 4:CD005111.
11. MacPherson H, Bland M, Bloor K, Cox H, Geddes D, Kang'ombe A, Reynolds J, Stamuli E, Stuardi T, Tilbrook H, et al. Acupuncture for irritable bowel syndrome: a protocol for a pragmatic randomised controlled trial. BMC Gastroenterol 2010, 10:63.
12. MacPherson H, Tilbrook H, Bland JM, Bloor K, Brabyn S, Cox H, Kang'ombe AR, Man MS, Stuardi T, Torgerson D, Watt I, Whorwell P. Acupuncture for irritable bowel syndrome: primary care based pragmatic randomised controlled trial. BMC Gastroenterology 2012, 12:139.
13. MacPherson H, et al. Acupuncture for irritable bowel syndrome: primary care based pragmatic randomised controlled trial. BMC Gastroenterology 2012, 12:150.
14. National Institute for Health and Clinical Excellence Guide to the methods of technology appraisal http://wwwniceorguk/media/B52/A7/TAMethodsGuideUpdatedJune2008pdf 2008, National Institute for Health and Clinical Excellence.
15. Kind P. EuroQol instrument: an index of health-related quality of life. Quality of life and pharmacoeconomics in clinical trials 1996, Philadelphia: Lippincott-Raven, Spilker B.
16. Dolan P, Gudex C, Kind P, Williams A. A social tarif for EuroQol: Results from a UK general population survey 1995, University of York: York, Discussion Paper No 138, Centre for Health Economics.
17. Curtis L. Unit Costs of Health and Social Care. 2010, . http://wwwpssruacuk/pdf/uc/uc2010/uc2010pdf 2010.
18. NHS reference cost 2009-2010 NHS trust and PCT combined reference costs schedules. . http://wwwdhgovuk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_123459, NHS reference cost 2009-2010.
19. NHS choices website . http://wwwnhsuk/Conditions/Acupuncture/Pages/Introductionaspx Accessed February 2011, NHS choices website.
20. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectivenessanalysis: the importance of controlling for baseline utility. Health Econ 2005, 14:487-496.
21. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997, 11:395-402.
22. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000, 119:654-660.
23. Miller V, Hopkins L, Whorwell PJ. Suicidal ideation in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2004, 2:1064-1068.